about
A Phase 1 dose-finding and pharmacodynamic study of rapamycin in combination with bevacizumab in patients with unresectable hepatocellular carcinoma.Impact of Smoking and Brain Metastasis on Outcomes of Advanced EGFR Mutation Lung Adenocarcinoma Patients Treated with First Line Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors.Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in Asian patients: 100 consecutive patients in a single institution.Prospective Quality of Life Study for Colorectal Cancer Patients with Peritoneal Carcinomatosis Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.Quality of life in patients with peritoneal surface malignancies after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.Primary intracranial germ cell tumours: experience of a single South-East Asian institution.Unresectability during open surgical exploration in planned cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.Is the Memorial Sloan Kettering Cancer Centre (MSKCC) sarcoma nomogram useful in an Asian population?Xerostomia, salivary characteristics and gland volumes following intensity-modulated radiotherapy for nasopharyngeal carcinoma: two year follow-up.Influence of afatinib dose on outcomes of advanced EGFR-mutant NSCLC patients with brain metastasesColorectal peritoneal carcinomatosis treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: the experience of a tertiary Asian centerAge exerts a continuous effect in the outcomes of Asian breast cancer patients treated with breast-conserving therapyCytoreductive surgery and hyperthermic intraperitoneal chemotherapy in recurrent ovarian cancer with peritoneal metastasis: a prospective registry study on 41 patients
P50
Q33404971-49B87589-8062-41D1-AF1D-26D3F4D55BD2Q35587238-CDCE71A7-2097-468A-AF26-EDA859D39E20Q38090517-825B09F7-4B07-4B78-B51A-F0F2BF77AC33Q47789478-6B3EE245-82F3-44D4-82BF-FDE24F6DE998Q48078247-06D7FE04-16F6-4F42-8D03-4EC8D8364B63Q48703322-A82FDD8A-05E9-4E94-A038-577392D0FB95Q50578314-B9F731E4-481E-44B8-B6F9-BCE0777C9416Q51055454-DBC98463-C261-4B39-B70D-A38A1568B0AFQ51736172-D27425CF-4424-4DEC-A90C-642B70E5BAD6Q59794876-937CDC1F-D5B9-4CDE-800C-4227B1D2A0FAQ87439621-E0EDE2E8-578C-4137-89F8-E7D3D197A6F7Q89238172-54CD279F-FD62-4841-BF03-90A23FD11FB0Q92618016-AC0F093B-1923-41D0-8C1A-7E7812872A31
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Cindy Lim
@ast
Cindy Lim
@en
Cindy Lim
@es
Cindy Lim
@nl
Cindy Lim
@sl
type
label
Cindy Lim
@ast
Cindy Lim
@en
Cindy Lim
@es
Cindy Lim
@nl
Cindy Lim
@sl
prefLabel
Cindy Lim
@ast
Cindy Lim
@en
Cindy Lim
@es
Cindy Lim
@nl
Cindy Lim
@sl
P106
P21
P31
P496
0000-0002-8036-4554